(PharmaNewsWire.Com, February 02, 2017 ) With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal testing. Presently, the government bodies are focused mainly towards development of non-invasive solutions, launching a large number of screening programs, controlling the increasing cases of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients. Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper testing and diagnosis of the disease.
This study includes an overview and analysis of the prenatal testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal testing market report presents a detailed analysis of market dynamics and provides an extensive insight into the various forms of development, trends, and key participants. All of the above mentioned report coverage parameters are discussed across different regions like North America, Europe, Asia Pacific (APAC), and Rest of the World (ROW) and further subdivided into major countries of each region. For report coverage and primaries, we have contacted industry experts and consultants in countries like U.S., U.K., Spain, China, India, Germany, Spain, France and Italy among others.
The answers to the following key questions can be found in the report: - What are the major market drivers, challenges and opportunities of the prenatal testing market and their use cases? - What are the key trends and developments in the prenatal testing market for genetic disease management? - What are the key developmental strategies in different applications across all regions? - What are the different types of prenatal tests and the latest technologies entering the market? - How will the key market players leverage on key developments such as mergers and acquisitions, partnerships, and product launches among others? - Which geographical region will lead the global prenatal testing market by the end of the forecast period? - Who are the key players in the global prenatal testing market? - What are the key government regulations for different prenatal tests and techniques? - What are the recent key market trends and key developments in different geographical regions? - What types of non-invasive and invasive prenatal screening tests are performed during a pregnancy? - What is the global and regional market for prenatal tests, through forecast period? - What is the global and regional market for NIPTs through 2022? - What is the status of prenatal testing in developed, developing and other countries?
While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal testing market. The research incorporates Porterís five force model for an in-depth analysis of the prenatal testing market and an assessment of the factors governing the same. The analysis builds on a well-compiled value chain, giving a detailed understanding of the ecosystem players and their rate of market penetration. The report includes the profiles of major players in the prenatal testing market that allows the readers to gain an insight into the various industry trends.
Executive Summary 1 Research Scope and Methodology 23 1.1 Scope of the Report 23 1.2 Global Prenatal Testing Market Research Methodology 25 1.2.1 Primary Data Sources 25 1.2.2 Secondary Data Sources 26 2 Introduction to the Prenatal Testing Market 27 3 Market Dynamics 37 3.1 Market Drivers 37 3.1.1 Emphasis on Early Detection and Prevention 38 3.1.2 Increasing Genetic and Congenital Disorders 38 3.1.3 Availability of Advanced Diagnosis and Screening Technologies 39 3.1.4 Evolving Government Initiatives 40 3.1.5 Adoption by Physicians: Incorporation of Tests into Clinical Care 40 3.1.6 Shifting of Reimbursement Policies towards more Genetics Coverage 40 3.2 Market Challenges 41 3.2.1 Risk of Ethical Issues and Social Stigma 42 3.2.2 Lack of Awareness among Consumers 42 3.2.3 High Cost of Screening and Diagnosis along with the Lack of Accuracy 43 3.3 Market Opportunities 43 3.3.1 Availability of Direct to Consumer Tests 44 3.3.2 Focus toward Pre-Implantation Genetic Diagnosis 44 4 Competitive Insights 46 4.1 Key Market Developments & Strategies 46 4.1.1 New Product Launch, Development and Expansion 47 4.1.2 Acquisitions, Partnerships and Collaborations 50 4.1.3 Business Expansion and Others 56 4.2 Industry Attractiveness 60 5 Industry Analysis 65 5.1 Patent Analysis 65 5.2 Consortiums, Alliances and Regulatory Bodies 69 5.3 Value Chain Analysis 72 6 Global Prenatal Testing Market, Analysis & Forecast 74 6.1 Assumptions & Limitations for Analysis and Forecast of the Global Prenatal Testing Market 74 6.2 Market Overview 75 6.3 Global Prenatal Testing Market by Screening Methods 77 6.3.1 Non-Invasive Prenatal Tests (NIPT) 79 18.104.22.168 NIPT Market by Geography 80 22.214.171.124 North America NIPT Market 82 126.96.36.199.1 Market Share Analysis by Countries 83 188.8.131.52.1.1 The U.S. 83 184.108.40.206.1.2 Canada 84 220.127.116.11.1.3 Mexico 85 18.104.22.168 Europe NIPT Market 86 22.214.171.124.1 Market Share Analysis by Countries 87 126.96.36.199.1.1 Germany 87 188.8.131.52.1.2 France 87 184.108.40.206.1.3 Italy 88 220.127.116.11.1.4 U.K. 89 18.104.22.168.1.5 Spain 89 22.214.171.124.1.6 Other European Countries 90 126.96.36.199 APAC NIPT Market: 91 188.8.131.52.1 Market Share Analysis by Countries 92 184.108.40.206.1.1 China 92 220.127.116.11.1.2 India 92 18.104.22.168.1.3 Japan 93 22.214.171.124.1.4 Other APAC Countries 94 126.96.36.199 Rest of the World NIPT Market 95 6.3.2 Other Prenatal Screening Tests 96 188.8.131.52 Cell-Free Fetal DNA Test 96 184.108.40.206 Maternal Serum Screening (MSS) 98 220.127.116.11 Nuchal Scan (NT Procedure) 98 18.104.22.168 Triple Test 98 22.214.171.124 Quadruple Test 98 6.4 Global Prenatal Testing Market by Diagnosis Methods 100 6.4.1 Global Prenatal Diagnosis Market by Test Type 102 126.96.36.199 Non-Invasive Prenatal Diagnosis Market 103 188.8.131.52.1 Ultrasonography 103 184.108.40.206.2 Fetal Cells in Maternal Blood (FCMB) 104 220.127.116.11.3 Pre-Implantation Genetic Diagnosis 104 18.104.22.168 Invasive Prenatal Diagnosis Market 104 22.214.171.124.1 Invasive Test Market by Test Types 104 126.96.36.199.1.1 Amniocentesis 105 188.8.131.52.1.2 Chorionic Villus Sampling (CVS) 107 184.108.40.206.1.3 Other Invasive Tests 110 220.127.116.11.1.3.1 Fetal Blood Sampling (FBS) 110 18.104.22.168.1.3.2 Transcervical Retrieval of Trophoblast Cells 110 22.214.171.124.1.3.3 Embryoscopy and Fetoscopy 111
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: